New tricks for human farnesyltransferase inhibitor: cancer and beyond
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New tricks for human farnesyltransferase inhibitor: cancer and beyond
Authors
Keywords
-
Journal
MedChemComm
Volume 8, Issue 5, Pages 841-854
Publisher
Royal Society of Chemistry (RSC)
Online
2017-02-17
DOI
10.1039/c7md00030h
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Latest Advances Towards Ras Inhibition: A Medicinal Chemistry Perspective
- (2016) Brice Sautier et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Discovery and preliminary structure–activity relationship studies on tecomaquinone I and tectol as novel farnesyltransferase and plasmodial inhibitors
- (2016) Melissa M. Cadelis et al. BIOORGANIC & MEDICINAL CHEMISTRY
- New indolizine–chalcones as potent inhibitors of human farnesyltransferase: Design, synthesis and biological evaluation
- (2016) Iuliana-Monica Moise et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view
- (2016) Shaoyong Lu et al. CHEMICAL SOCIETY REVIEWS
- Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria SyndromeClinical Perspective
- (2016) Leslie B. Gordon et al. CIRCULATION
- Recent advances in cancer drug discovery targeting RAS
- (2016) Candice Y. Wilson et al. DRUG DISCOVERY TODAY
- Low-Dose Farnesyltransferase Inhibitor Suppresses HIF-1α and Snail Expression in Triple-Negative Breast Cancer MDA-MB-231 Cells In Vitro
- (2016) Tomokazu Tanaka et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia
- (2016) Yanan Gao et al. Journal of Hematology & Oncology
- How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization
- (2016) Ethan J. Brock et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Protein prenylation: unique fats make their mark on biology
- (2016) Mei Wang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The role of wild type RAS isoforms in cancer
- (2016) Bingying Zhou et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Antitumor effect of manumycin on colorectal cancer cells by increasing the reactive oxygen species production and blocking PI3K-AKT pathway
- (2016) Jingyu Zhang et al. OncoTargets and Therapy
- Protein Prenylation Constitutes an Endogenous Brake on Axonal Growth
- (2016) Hai Li et al. Cell Reports
- Hallmarks of cancer and AU-rich elements
- (2016) Khalid S. A. Khabar Wiley Interdisciplinary Reviews-RNA
- Role of computer-aided drug design in modern drug discovery
- (2015) Stephani Joy Y. Macalino et al. ARCHIVES OF PHARMACAL RESEARCH
- Significance of KRAS/PAK1/Crk pathway in non-small cell lung cancer oncogenesis
- (2015) Fariborz Mortazavi et al. BMC CANCER
- Heart Disease and Stroke Statistics—2016 Update
- (2015) Dariush Mozaffarian et al. CIRCULATION
- Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?
- (2015) A. D. Cox et al. CLINICAL CANCER RESEARCH
- A novel role of farnesylation in targeting a mitotic checkpoint protein, human Spindly, to kinetochores
- (2015) Devinderjit K. Moudgil et al. JOURNAL OF CELL BIOLOGY
- Chemistry and biology of the compounds that modulate cell migration
- (2015) Etsu Tashiro et al. JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
- Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial
- (2015) Christopher Koh et al. LANCET INFECTIOUS DISEASES
- The Recent Development of Farnesyltransferase Inhibitors as Anticancer and Antimalarial Agents
- (2015) Yan Shen et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Preventing farnesylation of the dynein adaptor Spindly contributes to the mitotic defects caused by farnesyltransferase inhibitors
- (2015) Andrew J. Holland et al. MOLECULAR BIOLOGY OF THE CELL
- ASD v3.0: unraveling allosteric regulation with structural mechanisms and biological networks
- (2015) Qiancheng Shen et al. NUCLEIC ACIDS RESEARCH
- L744,832 and Everolimus Induce Cytotoxic and Cytostatic Effects in Non-Hodgkin Lymphoma Cells
- (2015) José Mendes et al. PATHOLOGY & ONCOLOGY RESEARCH
- Synthesis and biological evaluation of pentanedioic acid derivatives as farnesyltransferase inhibitors
- (2015) Liuqing Yang et al. MedChemComm
- Lonafarnib Is a Potential Inhibitor for Neovascularization
- (2015) Linlin Sun et al. PLoS One
- Antroquinonol blocks Ras and Rho signaling via the inhibition of protein isoprenyltransferase activity in cancer cells
- (2014) Ching-Liang Ho et al. BIOMEDICINE & PHARMACOTHERAPY
- Farnesyltransferase inhibitors: CAAX mimetics based on different biaryl scaffolds
- (2014) Valentina Straniero et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Novel indolizine derivatives with unprecedented inhibitory activity on human farnesyltransferase
- (2014) Carmen Dumea et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Molecular Pathways: Targeting the Dependence of Mutant RAS Cancers on the DNA Damage Response
- (2014) E. Grabocka et al. CLINICAL CANCER RESEARCH
- A RAS Renaissance: Emerging Targeted Therapies for KRAS-Mutated Non-Small Cell Lung Cancer
- (2014) N. Vasan et al. CLINICAL CANCER RESEARCH
- Dietary flavonoids fisetin and myricetin: Dual inhibitors of Plasmodium falciparum falcipain-2 and plasmepsin II
- (2014) Huangtao Jin et al. FITOTERAPIA
- Ras-induced Epigenetic Inactivation of theRRAD(Ras-related Associated with Diabetes) Gene Promotes Glucose Uptake in a Human Ovarian Cancer Model
- (2014) Yan Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Drugging the undruggable RAS: Mission Possible?
- (2014) Adrienne D. Cox et al. NATURE REVIEWS DRUG DISCOVERY
- Farnesyltransferase Regulates Neutrophil Recruitment and Tissue Damage in Acute Pancreatitis
- (2014) Mohammed Merza et al. PANCREAS
- Activation of the RhoB Signaling Pathway by Thyroid Hormone Receptor β in Thyroid Cancer Cells
- (2014) Sayaka Ichijo et al. PLoS One
- Farnesyltransferase Inhibitor, Tipifarnib, Prevents Galactosamine/Lipopolysaccharide-Induced Acute Liver Failure
- (2014) Kazuhiro Shirozu et al. SHOCK
- The Structural Basis of ATP as an Allosteric Modulator
- (2014) Shaoyong Lu et al. PLoS Computational Biology
- Farnesyltransferase inhibitor R115777 protects against vascular disease in uremic mice
- (2013) Igor G. Nikolov et al. ATHEROSCLEROSIS
- Synthesis and biological evaluation of a new series of N-ylides as protein farnesyltransferase inhibitors
- (2013) Cristina-Maria Abuhaie et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Farnesyltransferase Inhibitors: A Comprehensive Review Based on Quantitative Structural Analysis
- (2013) N. Moorthy et al. CURRENT MEDICINAL CHEMISTRY
- Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cells
- (2013) H. Ding et al. HAEMATOLOGICA
- Effect of farnesyltransferase inhibition on cardiac remodeling in spontaneously hypertensive rats
- (2013) Xia Li et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Novel derivatives of aclacinomycin A block cancer cell migration through inhibition of farnesyl transferase
- (2013) Shigeyuki Magi et al. JOURNAL OF ANTIBIOTICS
- Farnesyltransferase Haplodeficiency Reduces Neuropathology and Rescues Cognitive Function in a Mouse Model of Alzheimer Disease
- (2013) Shaowu Cheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Heparin-binding epidermal growth factor-like growth factor eliminates constraints on activated Kras to promote rapid onset of pancreatic neoplasia
- (2013) K C Ray et al. ONCOGENE
- Transformation by HrasG12V is consistently associated with mutant allele copy gains and is reversed by farnesyl transferase inhibition
- (2013) X Chen et al. ONCOGENE
- Discovery of novel inhibitors for human farnesyltransferase (hFTase) via structure-based virtual screening
- (2013) Xiaojuan Yu et al. MedChemComm
- Ras and Rheb Signaling in Survival and Cell Death
- (2013) Anja Ehrkamp et al. Cancers
- Inhibition of farnesyltransferase reduces angiogenesis by interrupting endothelial cell migration
- (2012) Guoyuan Peng et al. BIOCHEMICAL PHARMACOLOGY
- Novel route to chaetomellic acid A and analogues: Serendipitous discovery of a more competent FTase inhibitor
- (2012) Franco Bellesia et al. BIOORGANIC & MEDICINAL CHEMISTRY
- New farnesyltransferase inhibitors in the phenothiazine series
- (2012) Dalila Belei et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Abstract 2876: Farnesyltransferase inhibitor induces p53-dependent cellular senescence in colon cancer cells
- (2012) Limin Zhu et al. CANCER RESEARCH
- Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non-small lung cancer cells
- (2012) G. Pelaia et al. CELL PROLIFERATION
- Is there a future for prenyltransferase inhibitors in cancer therapy?
- (2012) Sarah A Holstein et al. CURRENT OPINION IN PHARMACOLOGY
- Lonafarnib for cancer and progeria
- (2012) Nan Soon Wong et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- New protein farnesyltransferase inhibitors in the 3-arylthiophene 2-carboxylic acid series: diversification of the aryl moiety by solid-phase synthesis
- (2012) Sébastien Lethu et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- NRAS mutant melanoma: biological behavior and future strategies for therapeutic management
- (2012) I V Fedorenko et al. ONCOGENE
- Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome
- (2012) L. B. Gordon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Thiazole- and imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase
- (2011) Cristiano Bolchi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis and anti-migrative evaluation of moverastin derivatives
- (2011) Masato Sawada et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Inhibition of Ras for cancer treatment: the search continues
- (2011) Antonio T Baines et al. Future Medicinal Chemistry
- 3 FTI-277 inhibits vascular calcification by activating downstream Pi3k/Akt signalling and preventing apoptosis of vascular smooth muscle cells
- (2011) A. Ponnusamy et al. HEART
- Farnesyltransferase Inhibitor Manumycin Targets IL1β-Ras-HIF-1α Axis in Tumor Cells of Diverse Origin
- (2011) Vivek Sharma et al. INFLAMMATION
- Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells
- (2011) Su-Kyung Lee et al. INTERNATIONAL JOURNAL OF CANCER
- A multiplicity of anti-invasive effects of farnesyl transferase inhibitor SCH66336 in human head and neck cancer
- (2011) Seung Hyun Oh et al. INTERNATIONAL JOURNAL OF CANCER
- Matrix metalloproteinase-1 contribution to sarcoma cell invasion
- (2011) Nandor Garamszegi et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Autophagy as a therapeutic target in cardiovascular disease
- (2011) Andriy Nemchenko et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Fast and effective identification of the bioactive compounds and their targets from medicinal plants via computational chemical biology approach
- (2011) Shoude Zhang et al. MedChemComm
- Targeting the Tumor Microenvironment: Focus on Angiogenesis
- (2011) Fengjuan Fan et al. Journal of Oncology
- The Farnesyltransferase Inhibitor LB42708 Suppresses Vascular Endothelial Growth Factor-Induced Angiogenesis by Inhibiting Ras-dependent Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase/Akt Signal Pathways
- (2010) C.-K. Kim et al. MOLECULAR PHARMACOLOGY
- Atherosclerosis in CKD: differences from the general population
- (2010) Tilman B. Drüeke et al. Nature Reviews Nephrology
- Oncogenic Ras-Induced Expression of Cytokines: A New Target of Anti-Cancer Therapeutics
- (2008) B. B. Ancrile et al. MOLECULAR INTERVENTIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started